Does natural killer cell-based adoptive immunotherapy eradicate and drives differentiation of chemoresistant bladder cancer stem-like cells?
Although pre-clinical, our results strongly suggest that an immunotherapeutic strategy using allogeneic activated NK cells from healthy donors is effective and should be exploited as a complementary therapeutic strategy in high-risk NMIBC patients to prevent tumor recurrence and progression.
Magerl with posterior wiring and Harms techniques are both effective options for stabilizing the atlantoaxial complex. However, the Harms technique appears to be safer, to have fewer complications, and to demonstrate a more robust long-term fixation.